How real-time insight into rising drug prices can lead to lower costs and better health outcomes.

Keep Costs in Check in 2024

Each January, manufacturers announce changes to the list price for many of their products. While some prices may go down, many therapies see an increase.

Of the 775 drugs impacted by inflation so far, the median increase is 4.5 percent. While this number may seem insignificant, the effect on drug spend and member cost share adds up quickly.

In our new white paper, we take a closer look at 2024 drug price hikes on some widely used medications and offer detailed insight to help you:

  • Understand the potential impact on future drug spend.
  • Uncover how you can use this information,
    paired with analytics automation, to advise
    clients on ways to manage costs and keep
    members healthy.

Download the White Paper

This field is for validation purposes and should be left unchanged.


median price increase on


drugs and counting